Dmitry Genkin serves as Executive at Xenetic Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Dmitry Genkin has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 19, 2019 involved receiving (via award) 93,390 shares valued at $0.
Dmitry Genkin currently holds 93,603 shares of Xenetic Biosciences, Inc. (XBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dmitry Genkin has been a net neutral trader of XBIO stock. They have purchased $0 and sold $0 worth of shares.
Dmitry Genkin's most recent insider trade was on Jul 19, 2019, when they sold 93,390 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |